International Clinical Trial: Sleep spindle wave alterations as a new biomarker for phenotypic stratification in sporadic amyotrophic lateral sclerosis

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124897) titled 'Sleep spindle wave alterations as a new biomarker for phenotypic stratification in sporadic amyotrophic lateral sclerosis' on May 19.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The Second Hospital of Hebei Medical University

Condition: Amyotrophic Lateral Sclerosis

Intervention: ALS group:None

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-04-01

Target Sample Size: ALS group:114;Healthy control group:57;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=290727

Published by HT Digital Co...